KIR3DL2 Receptors
A KIR receptor that has specificity for HLA-A3 ANTIGEN. It is an inhibitory receptor that contains D0, D1, and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail.
Also Known As:
Receptors, KIR3DL2; CD158k Antigen; KIR3DL2 Receptor; Killer Cell Immunoglobulin-Like Receptor 3DL2; p140-KIR3DL2 Inhibitory Receptor; Antigen, CD158k; Inhibitory Receptor, p140-KIR3DL2; Killer Cell Immunoglobulin Like Receptor 3DL2; Receptor, KIR3DL2; Receptor, p140-KIR3DL2 Inhibitory; p140 KIR3DL2 Inhibitory Receptor; Antigens, CD158k; CD158k Antigens
Networked: 6
relevant articles (0 outcomes,
2 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Bagot, Martine:
3 articles
(08/2018 - 10/2014)
|
2. | Bensussan, Armand:
2 articles
(09/2015 - 10/2014)
|
3. | Marie-Cardine, Anne:
2 articles
(09/2015 - 10/2014)
|
4. | Sicard, Hélène:
2 articles
(09/2015 - 10/2014)
|
5. | Wang, Qi:
2 articles
(01/2011 - 06/2009)
|
6. | Darcy, Phil K:
1 article
(08/2018)
|
7. | Neeson, Paul:
1 article
(08/2018)
|
8. | Prince, H Miles:
1 article
(08/2018)
|
9. | Van Der Weyden, Carrie:
1 article
(08/2018)
|
10. | Bonnafous, Cécile:
1 article
(09/2015)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures